674P WITNESS: Real-world outcomes of patients (pts) with advanced renal cell carcinoma (aRCC) treated with nivolumab in France and subgroup analysis of patients receiving concomitant medications at baseline

Concomitant Medications

Elderly patients (pts) with advanced Renal Cell Carcinoma (aRCC) treated with Nivolumab (N): A subgroup analysis from the WITNESS real-world study in France

European Urology Open Science ◽

10.1016/s2666-1683(20)36230-3 ◽

2020 ◽

Vol 21 ◽

pp. S182

Author(s):

P. Barthélémy ◽

A. Thiery-Vuillemin ◽

B. Escudier ◽

J-C. Eymard ◽

G. Mouillet ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Elderly Patients ◽

Cell Carcinoma ◽

Real World ◽

Subgroup Analysis ◽

Renal Cell ◽

Randomized phase III trial of avelumab + axitinib vs sunitinib as first-line treatment for advanced renal cell carcinoma: JAVELIN renal 101 Japanese subgroup analysis

Annals of Oncology ◽

10.1093/annonc/mdz249.052 ◽

2019 ◽

Vol 30 ◽

pp. v386-v387

Author(s):

M. Uemura ◽

Y. Tomita ◽

H. Miyake ◽

S. Hatakeyama ◽

H.-O. Kanayama ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Subgroup Analysis ◽

Renal Cell ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Phase Iii Trial ◽

First Line Treatment

Analyses of Nivolumab Exposure and Clinical Safety Between 3-mg/kg Dosing and 240-mg Flat Dosing in Asian Patients with Advanced Renal Cell Carcinoma in the Real-World Clinical Setting

Translational Oncology ◽

10.1016/j.tranon.2020.100771 ◽

2020 ◽

Vol 13 (6) ◽

pp. 100771

Author(s):

Renpei Kato ◽

Daiki Ikarashi ◽

Tomohiko Matsuura ◽

Shigekatsu Maekawa ◽

Yoichiro Kato ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Clinical Setting ◽

Renal Cell ◽

Clinical Safety ◽

The Real ◽

Asian Patients

Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2019.01.018 ◽

2019 ◽

Vol 17 (3) ◽

pp. e526-e533 ◽

Cited By ~ 3

Author(s):

Giuseppe Procopio ◽

Aristotelis Bamias ◽

Manuela Schmidinger ◽

Robert Hawkins ◽

Angel Rodriguez Sánchez ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)

Annals of Oncology ◽

10.1093/annonc/mdy283.093 ◽

2018 ◽

Vol 29 ◽

pp. viii313

Author(s):

G. Procopio ◽

A. Bamias ◽

M. Schmidinger ◽

R. Hawkins ◽

A. Rodriguez Sanchez ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Real world evidence in renal cell carcinoma: A national, prospective, non-interventional study of nivolumab in patients with advanced renal cell carcinoma after prior therapy (NORA)

European Urology Supplements ◽

10.1016/s1569-9056(19)31333-8 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1841

Author(s):

M-O. Grimm ◽

V. Grünwald ◽

H. Müller-Huesmann ◽

M. Schostak ◽

W. Schultze-Seemann ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Interventional Study ◽

Prior Therapy ◽

Real World Evidence

682P Real-world utilization and outcomes of immune-based combination therapies or tyrosine kinase inhibitors (TKIs) for advanced renal cell carcinoma (aRCC)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.078 ◽

2021 ◽

Vol 32 ◽

pp. S702

Author(s):

D. Geynisman ◽

J.K. Kish ◽

A. Falkenstein ◽

V. Del Tejo ◽

B. Stwalley ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Real World ◽

Renal Cell ◽

Kinase Inhibitors ◽

Combination Therapies

Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma after Prior Therapy: Interim Results from the Noninterventional NORA Study

European Urology Focus ◽

10.1016/j.euf.2021.11.006 ◽

2021 ◽

Author(s):

Marc-Oliver Grimm ◽

Viktor Grünwald ◽

Harald Müller-Huesmann ◽

Philipp Ivanyi ◽

Martin Schostak ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Real World Data ◽

World Data ◽

Prior Therapy

Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyv045 ◽

2015 ◽

Vol 45 (6) ◽

pp. 576-583 ◽

Cited By ~ 27

Author(s):

Hideyuki Akaza ◽

Seiji Naito ◽

Naomi Ueno ◽

Kouji Aoki ◽

Hiroyuki Houzawa ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Japanese Patients ◽

Faculty Opinions recommendation of Cabozantinib, a new standard of care for patients with advanced renal cell carcinoma and bone metastases? subgroup analysis of the METEOR trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732415195.793543328 ◽

2018 ◽

Author(s):

Anil Sood

Keyword(s):

Renal Cell Carcinoma ◽

Bone Metastases ◽

Cell Carcinoma ◽

Subgroup Analysis ◽

Renal Cell ◽

Standard Of Care ◽